Table 2.
Gene/Proteins/Peptides | Carrier System | Function | References |
---|---|---|---|
siRNA |
β-CD-(D3)7; nanometer-scale coatings. |
Decreasing MMP-9 expression. | [78,79] |
Keap1 siRNA | Lipoproteoplex delivers | Activate Nrf2-mediated endogenous antioxidant mechanisms, normalize the ROS imbalance. | [81] |
miR-26a | PCN hydrogel | Offer the proregenerative wound microenvironment and proangiogenic miRNAs. | [77] |
Plasmid DNA encoding VEGF |
Ga-BDEs | Enhance sustained expression of VEGF. | [80] |
Heparin mimetic peptide amphiphiles |
Nanofibers | Enhance production and activity of major angiogenic growth factors (VEGF). | [84] |
DMOG | PCL fiber meshes | Reducing the expression of pro-inflammatory factors (IL-1β,IL-6, and TNF-α), increasing anti-inflammatory factors (TGF-β1 and IL-4) and GFs (IGF-1, HB-EGF, NGF, and bFGF), and promoting angiogenesis (CD-31 and VEGF-α). | [86] |
K2(SL)6K2 | MDP hydrogels | Allowing rapid cellular infiltration, and thus are ideal for tissue engineering strategies. | [91] |
Proline | IKFQFHFD hydrogel | Eradicate MRSA biofilm. | [85] |
Spider silk fusion proteins | Nanofibrous mats of AaSF | Efficient matrix remodelling of wounds. | [93] |
Heparin or bemiparin | CS hydrogels | Improved diabetes-associated impaired wound healing. | [87] |
Nucleic acids | tFNAs | Antioxidant activity via the Akt/Nrf2/HO-1 signaling pathway. | [88] |
Integrin | Silk fibroin nanosheets | Regulate angiogenesis and promote diabetic ulcer healing. | [92] |
Laminin mimetic peptide SIKVAV | CS hydrogels | Significantly promoted BMSCs adhesion and proliferation. | [89] |
MMP‑9 inhibitor (R)‑ND-336 | Linezolid | Inhibiting the detrimental MMP-9, mitigating macrophage infiltration to diminish inflammation | [90] |